Terms: = Endocrine gland cancer AND DDX6, P54, 1656, ENSG00000110367, HLR2, P26196, RCK, FLJ36338
22 results:
1. A Multi-Faceted Analysis Showing
Balcerak A; Szafron LA; Rubel T; Swiderska B; Bonna AM; Konarzewska M; Sołtyszewski I; Kupryjanczyk J; Szafron LM
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673965
[No Abstract] [Full Text] [Related]
2. The ddx6/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer.
Deng X; Liu Z; Wang B; Ma J; Meng X
FASEB J; 2024 Apr; 38(7):e23581. PubMed ID: 38551642
[TBL] [Abstract] [Full Text] [Related]
3. CX3CR1 is a potential biomarker of immune microenvironment and prognosis in epithelial ovarian cancer.
Shao D; Zhou H; Yu H; Zhu X
Medicine (Baltimore); 2024 Jan; 103(3):e36891. PubMed ID: 38241595
[TBL] [Abstract] [Full Text] [Related]
4. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid.
Lennartz M; Csomós H; Chirico V; Weidemann S; Gorbokon N; Menz A; Büscheck F; Hube-Magg C; Höflmayer D; Bernreuther C; Blessin NC; Lebok P; Sauter G; Steurer S; Burandt E; Dum D; Krech T; Simon R; Minner S; Jacobsen F; Clauditz TS; Luebke AM; Siraj AK; Al-Dayel F; Al-Kuraya KS; Hinsch A
Sci Rep; 2023 Aug; 13(1):12917. PubMed ID: 37558687
[TBL] [Abstract] [Full Text] [Related]
5. Surgical approach to pancreaticoduodenectomy for pancreatic adenocarcinoma: uncomplicated ends justify the means.
Naffouje SA; Pointer DT; Satyadi MA; Hodul P; Anaya DA; Pimiento J; Malafa M; Kim DW; Fleming JB; Denbo JW
Surg Endosc; 2022 Jul; 36(7):4912-4922. PubMed ID: 34859301
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties.
Lucà R; Assenza MR; Maiullari F; Pieroni L; Maiullari S; Federici G; Marini F; Rizzi R; Urbani A; Soddu S; Moretti F
Cell Death Dis; 2021 May; 12(6):558. PubMed ID: 34052831
[TBL] [Abstract] [Full Text] [Related]
7. Sonographic Assessment of the Extent of Extrathyroidal Extension in Thyroid cancer.
Chung SR; Baek JH; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
Korean J Radiol; 2020 Oct; 21(10):1187-1195. PubMed ID: 32729261
[TBL] [Abstract] [Full Text] [Related]
8. Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.
Pellarin I; Dall'Acqua A; Gambelli A; Pellizzari I; D'Andrea S; Sonego M; Lorenzon I; Schiappacassi M; Belletti B; Baldassarre G
Oncogene; 2020 May; 39(22):4390-4403. PubMed ID: 32332923
[TBL] [Abstract] [Full Text] [Related]
9. Loss of BAP1 Leads to More YAPing in Pancreatic cancer.
Brekken RA
Cancer Res; 2020 Apr; 80(8):1624-1625. PubMed ID: 32295782
[TBL] [Abstract] [Full Text] [Related]
10. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
[TBL] [Abstract] [Full Text] [Related]
11. Microarray-based identification of genes associated with prognosis and drug resistance in ovarian cancer.
Yin F; Yi S; Wei L; Zhao B; Li J; Cai X; Dong C; Liu X
J Cell Biochem; 2019 Apr; 120(4):6057-6070. PubMed ID: 30335894
[TBL] [Abstract] [Full Text] [Related]
12. Imsnc761 and ddx6 synergistically suppress cell proliferation and promote apoptosis via p53 in testicular embryonal carcinoma cells.
Duan Z; Ping P; Wang G; Zhang X; Sun F
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769412
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic values of excision repair cross-complementing genes mRNA expression in ovarian cancer patients.
Zhao M; Li S; Zhou L; Shen Q; Zhu H; Zhu X
Life Sci; 2018 Feb; 194():34-39. PubMed ID: 29247747
[TBL] [Abstract] [Full Text] [Related]
14. Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: A cohort of 1656 patients.
Hao L; Zeng XP; Xin L; Wang D; Pan J; Bi YW; Ji JT; Du TT; Lin JH; Zhang D; Ye B; Zou WB; Chen H; Xie T; Li BR; Zheng ZH; Wang T; Guo HL; Liao Z; Li ZS; Hu LH
Dig Liver Dis; 2017 Nov; 49(11):1249-1256. PubMed ID: 28756974
[TBL] [Abstract] [Full Text] [Related]
15. DDA1 is induced by NR2F6 in ovarian cancer and predicts poor survival outcome.
Liu J; Li T; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1206-1213. PubMed ID: 28387912
[TBL] [Abstract] [Full Text] [Related]
16. Strategies for Increasing Pancreatic Tumor Immunogenicity.
Johnson BA; Yarchoan M; Lee V; Laheru DA; Jaffee EM
Clin Cancer Res; 2017 Apr; 23(7):1656-1669. PubMed ID: 28373364
[TBL] [Abstract] [Full Text] [Related]
17. Target specificity of 188Re-labeled B27.1 monoclonal antibodies to ovarian cancer cells in vivo.
Palakurthi S; Wilson J; McQuarrie SA; Suresh MR; Mercer JR; Miller GG
In Vivo; 2008; 22(3):321-6. PubMed ID: 18610743
[TBL] [Abstract] [Full Text] [Related]
18. Medullary thyroid carcinoma in Hong Kong Chinese patients.
Chow SM; Chan JK; Tiu SC; Choi KL; Tang DL; Law SC
Hong Kong Med J; 2005 Aug; 11(4):251-8. PubMed ID: 16085941
[TBL] [Abstract] [Full Text] [Related]
19. Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions.
Cavaco BM; Domingues R; Bacelar MC; Cardoso H; Barros L; Gomes L; Ruas MM; Agapito A; Garrão A; Pannett AA; Silva JL; Sobrinho LG; Thakker RV; Leite V
Clin Endocrinol (Oxf); 2002 Apr; 56(4):465-73. PubMed ID: 11966739
[TBL] [Abstract] [Full Text] [Related]
20. [Role of Doppler color ultrasonography in the diagnosis of thyroid carcinoma].
Summaria V; Mirk P; Costantini AM; Maresca G; Ardito G; Bellantone R; Marano P
Ann Ital Chir; 2001; 72(3):277-82. PubMed ID: 11765344
[TBL] [Abstract] [Full Text] [Related]
[Next]
